ImmunityBio (IBRX) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.79% |
| Dec 31, 2025 | 67.12% |
| Sep 30, 2025 | 65.69% |
| Jun 30, 2025 | 97.39% |
| Mar 31, 2025 | 81.82% |
| Dec 31, 2024 | 48.04% |
| Sep 30, 2024 | 93.37% |
| Jun 30, 2024 | 79.17% |
| Mar 31, 2024 | 43.66% |
| Dec 31, 2023 | 55.46% |
| Sep 30, 2023 | 29.50% |
| Jun 30, 2023 | 4.37% |
| Mar 31, 2023 | 3.70% |
| Dec 31, 2022 | 1.03% |
| Sep 30, 2022 | 4.06% |
| Jun 30, 2022 | 1.64% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | -2.01% |
| Sep 30, 2021 | -5.81% |
| Jun 30, 2021 | -5.22% |
| Mar 31, 2021 | -5.74% |
| Dec 31, 2020 | -49.97% |
| Sep 30, 2020 | -55.11% |
| Jun 30, 2020 | -69.71% |
| Mar 31, 2020 | -54.47% |
| Dec 31, 2019 | 16.47% |
| Sep 30, 2019 | 57.04% |
| Jun 30, 2019 | 74.78% |
| Dec 31, 2018 | 9.35% |